In FCD, while there was no evidence of differences in glutamate and glutamine at the site, N-acetyl aspartate showed a significant reduction compared to the NACS
Evaluating the efficacy of the treatment with benfotiamine and alpha-lipoic acid in distal symmetric painful diabetic polyneuropathy
2.2 Key Patent Expiry Dates and Early Launches For GLP-1 drugs, patent timing has played a critical role: Indian government and ICMR documents note that, as a concrete milestone, the core patent for semaglutide expired on March 20, 2026, triggering immediate generic launches and a sharp price drop across India.[4] According to Business Standard, more than 40 Indian drugmakers including Sun Pharma, Dr
CPT is a registered trademark of the American Medical Association
Contact your GP for generalised rashes, persistent injection site reactions beyond a few days, or any concerning skin changes